Cargando…
Rapid Progression of Polypoidal Choroidal Vasculopathy following Third BNT162b2 mRNA Vaccination
The study aimed to describe a case of rapid progression of polypoidal choroidal vasculopathy (PCV) following the third administration of the Pfizer-BioNTech (BNT162b2) mRNA vaccine. A 79-year-old Japanese man visited our hospital with a 1-week history of blurred vision in the left eye 16 h following...
Autores principales: | Sasajima, Hirofumi, Zako, Masahiro, Maeda, Rio, Ueta, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247562/ https://www.ncbi.nlm.nih.gov/pubmed/35950020 http://dx.doi.org/10.1159/000525151 |
Ejemplares similares
-
Polypoidal Choroidal Vasculopathy in Asians
por: Wong, Chee Wai, et al.
Publicado: (2015) -
Choroidal Nevus in an Eye with Polypoidal Choroidal Vasculopathy
por: Asao, Kazunobu, et al.
Publicado: (2014) -
Foveal Intraretinal Fluid Localization Affects the Visual Prognosis of Branch Retinal Vein Occlusion
por: Sasajima, Hirofumi, et al.
Publicado: (2022) -
Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015) -
Polypoidal Choroidal Vasculopathy in Congolese Patients
por: Kabedi, Nelly N., et al.
Publicado: (2020)